InfiniteBio

InfiniteBio connects the worlds of science, technology, and investment
across national and cultural borders

Featured Technologies

In Vitro Assay System
In Vitro Cardiotoxicity Assay System QTempo from ReproCELL	GLP-1 and GIP primary cell assay services from ReproCELL

Cell Culture Systems
Cell Culture Reagents for Primate ES/iPS Cells and Antibodies from ReproCELL	3D Cell Culture NanoCulture® System from SCIVAX Product Page

Metabolome Analysis Service

Metabolome Analysis Service by CE-MS
from Human Metabolome Technologies

In Vivo Models
Knock-out Mouse Models 1. Bipolar Mouse Model 2. Schizophrenia Mouse Model	PXB Mouse Model from PhoenixBio

ReproCELL and its technologies are featured in an article in Genetic Engineering & Biotechnology News, "Pharma's R&D Focus Shifting to Stem Cells"

"U.S. Graduate Schools: A Path for Global Scientists & Engineers" written by Kagakusha NET was published. Akiko Futamura participated as a contributing author.
>> buy the book

【Conferences】

May 17-19, 2010
Applied Pharmaceutical Toxicology 2010
Dr. Futamura will give a talk entitled "Stem Cell-Derived Functional Cardiomyocytes for Toxicity Prediction".

April 17-21, 2010
AACR 101st Annual Meeting 2010
InfiniteBio will have booth #923 to promote novel in vitro technologies.

Mar 7-11, 2010
The 49th Annual Meeting of the Society of Toxicology
InfiniteBio and ITOCHU will have booth #2042 to promote ReproCELL's new cardiotoxicity assay, QTempo.

Jan 22, 2010
Osaka University the 5th Innovation Forum Our CEO, Akiko Futamura, will be a panelist.